ANI Pharmaceuticals | ANIP - Ebit





Ebit Cambiamento Data
AbbVie USD 4.73B 1.08B 2026-03
ANI Pharmaceuticals USD 29.13M 6.3M 2025-12
Aurora Cannabis CAD -35.79M 8.96M 2025-12
Canopy Growth CAD -12.66M 1.64M 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Heron Therapeutics USD 38K 3.83M 2025-12
Hikma Pharmaceutical USD 348M 31M 2025-12
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Novartis USD 4.06B 413M 2025-12
Omeros USD -48.15M 7.25M 2023-09
Perrigo USD 84.4M 9M 2025-12
Sun Pharmaceuticals INR 40.62B 6.95B 2025-12
Teva Pharmaceutical Industries USD 758M 181M 2026-03